Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.09B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$984M |
| 3 |
Pfizer
PFE
|
+$895M |
| 4 |
Johnson & Johnson
JNJ
|
+$862M |
| 5 |
American Express
AXP
|
+$773M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.04% |
| 2 | Technology | 14.87% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Staples | 8.81% |
| 5 | Consumer Discretionary | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABB
351
DELISTED
ABB Ltd
ABB
| $486K | ﹤0.01% |
+22,455
| New | +$497K |
|
352
Emerson Electric
EMR
$83.3B
| $466K | ﹤0.01% |
+8,553
| New | +$481K |
|
|
CAM
353
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $462K | ﹤0.01% |
+7,554
| New | +$470K |
|
354
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $449K | ﹤0.01% |
+5,404
| New | +$469K |
|
355
Lowe's Companies
LOW
$118B
| $445K | ﹤0.01% |
+10,884
| New | +$438K |
|
356
Norfolk Southern
NSC
$75B
| $420K | ﹤0.01% |
+5,786
| New | +$442K |
|
357
NOV
NOV
$6.88B
| $413K | ﹤0.01% |
+6,655
| New | +$410K |
|
|
BRS
358
DELISTED
Bristow Group, Inc.
BRS
| $412K | ﹤0.01% |
+6,300
| New | +$403K |
|
359
Medtronic
MDT
$110B
| $397K | ﹤0.01% |
+7,713
| New | +$381K |
|
360
SPDR Gold Trust
GLD
$133B
| $396K | ﹤0.01% |
+3,326
| New | +$456K |
|
361
ATI
ATI
$24.8B
| $395K | ﹤0.01% |
+15,000
| New | +$423K |
|
362
Cenovus Energy
CVE
$55.9B
| $390K | ﹤0.01% |
+13,668
| New | +$404K |
|
363
Biogen
BIIB
$30.7B
| $380K | ﹤0.01% |
+1,767
| New | +$378K |
|
364
Abbott
ABT
$183B
| $373K | ﹤0.01% |
+10,685
| New | +$392K |
|
365
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $356K | ﹤0.01% |
+3,478
| New | +$371K |
|
366
Goldman Sachs
GS
$302B
| $353K | ﹤0.01% |
+2,333
| New | +$356K |
|
|
ETP
367
DELISTED
Energy Transfer Partners L.p.
ETP
| $352K | ﹤0.01% |
+6,974
| New | +$344K |
|
368
Eastman Chemical
EMN
$8.01B
| $344K | ﹤0.01% |
+4,909
| New | +$342K |
|
369
Tapestry
TPR
$30.8B
| $339K | ﹤0.01% |
+5,935
| New | +$334K |
|
370
Southern Company
SO
$109B
| $336K | ﹤0.01% |
+7,623
| New | +$351K |
|
371
Blackrock
BLK
$170B
| $335K | ﹤0.01% |
+1,305
| New | +$350K |
|
372
Capital Southwest
CSWC
$1.47B
| $331K | ﹤0.01% |
+26,150
| New | +$308K |
|
373
Honeywell
HON
$76.7B
| $330K | ﹤0.01% |
+4,626
| New | +$319K |
|
374
iShares China Large-Cap ETF
FXI
$4.37B
| $325K | ﹤0.01% |
+9,992
| New | +$360K |
|
375
Deere & Co
DE
$162B
| $319K | ﹤0.01% |
+3,924
| New | +$339K |
|
Similar funds
Ken Fisher's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Ken Fisher, which disclosed 525 positions worth $38.5B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Barclays ETN+ FI Enhanced Global High Yield ETN: 11,772,806 shares worth $1.05B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2013 buy was Barclays ETN+ FI Enhanced Global High Yield ETN: 11,772,806 shares worth $1.05B.
- Ken Fisher's ten largest holdings make up 21% of its $38.5B portfolio in Q2 2013.
- Ken Fisher disclosed 525 positions in Q2 2013, its first 13F filing on record.
Based on Fisher Asset Management's 13F filing for Q2 2013, filed 16 Jul 2013.